148 related articles for article (PubMed ID: 12671308)
1. Oxidative toxicity in models of neurodegeneration: responses to melatonin.
Reiter RJ; Garcia JJ; Pie J
Restor Neurol Neurosci; 1998 Jun; 12(2-3):135-42. PubMed ID: 12671308
[TBL] [Abstract][Full Text] [Related]
2. Suppression of oxygen toxicity by melatonin.
Reiter RJ; Tan DX; Qi WB
Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
[TBL] [Abstract][Full Text] [Related]
3. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
Reiter RJ; Acuña-Castroviejo D; Tan DX; Burkhardt S
Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage in the central nervous system: protection by melatonin.
Reiter RJ
Prog Neurobiol; 1998 Oct; 56(3):359-84. PubMed ID: 9770244
[TBL] [Abstract][Full Text] [Related]
5. Melatonin in relation to cellular antioxidative defense mechanisms.
Reiter RJ; Carneiro RC; Oh CS
Horm Metab Res; 1997 Aug; 29(8):363-72. PubMed ID: 9288572
[TBL] [Abstract][Full Text] [Related]
6. Melatonin oxidative stress and neurodegenerative diseases.
Srinivasan V
Indian J Exp Biol; 2002 Jun; 40(6):668-79. PubMed ID: 12587715
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.
Reiter RJ; Guerrero JM; Garcia JJ; Acuña-Castroviejo D
Ann N Y Acad Sci; 1998 Nov; 854():410-24. PubMed ID: 9928448
[TBL] [Abstract][Full Text] [Related]
8. The oxidant/antioxidant network: role of melatonin.
Reiter RJ; Tan DX; Cabrera J; D'Arpa D; Sainz RM; Mayo JC; Ramos S
Biol Signals Recept; 1999; 8(1-2):56-63. PubMed ID: 10085463
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
Gupta YK; Gupta M; Kohli K
Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
[TBL] [Abstract][Full Text] [Related]
10. High glucose mediates pro-oxidant and antioxidant enzyme activities in coronary endothelial cells.
Weidig P; McMaster D; Bayraktutan U
Diabetes Obes Metab; 2004 Nov; 6(6):432-41. PubMed ID: 15479219
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of melatonin in oxygen radical pathophysiology.
Reiter R; Tang L; Garcia JJ; Muñoz-Hoyos A
Life Sci; 1997; 60(25):2255-71. PubMed ID: 9194681
[TBL] [Abstract][Full Text] [Related]
12. Actions of melatonin in the reduction of oxidative stress. A review.
Reiter RJ; Tan DX; Osuna C; Gitto E
J Biomed Sci; 2000; 7(6):444-58. PubMed ID: 11060493
[TBL] [Abstract][Full Text] [Related]
13. Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.
Reiter RJ; Cabrera J; Sainz RM; Mayo JC; Manchester LC; Tan DX
Ann N Y Acad Sci; 1999; 890():471-85. PubMed ID: 10668453
[TBL] [Abstract][Full Text] [Related]
14. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma.
Maldonado MD; Murillo-Cabezas F; Terron MP; Flores LJ; Tan DX; Manchester LC; Reiter RJ
J Pineal Res; 2007 Jan; 42(1):1-11. PubMed ID: 17198533
[TBL] [Abstract][Full Text] [Related]
15. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage.
Maldonado MD; Murillo-Cabezas F; Calvo JR; Lardone PJ; Tan DX; Guerrero JM; Reiter RJ
Crit Care Med; 2007 Apr; 35(4):1177-85. PubMed ID: 17312564
[TBL] [Abstract][Full Text] [Related]
16. Influence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes--an in vitro study.
Zwirska-Korczala K; Jochem J; Adamczyk-Sowa M; Sowa P; Polaniak R; Birkner E; Latocha M; Pilc K; Suchanek R
J Physiol Pharmacol; 2005 Dec; 56 Suppl 6():91-9. PubMed ID: 16340042
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
[TBL] [Abstract][Full Text] [Related]
18. Melatonin ameliorates renal ischemia/reperfusion injury.
Rodríguez-Reynoso S; Leal C; Portilla-de Buen E; Castillo JC; Ramos-Solano F
J Surg Res; 2004 Feb; 116(2):242-7. PubMed ID: 15013362
[TBL] [Abstract][Full Text] [Related]
19. Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration.
Gómez M; Esparza JL; Nogués MR; Giralt M; Cabré M; Domingo JL
Free Radic Biol Med; 2005 Jan; 38(1):104-11. PubMed ID: 15589378
[TBL] [Abstract][Full Text] [Related]
20. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]